Latest filing published 01 Sept 2026 for Marvel Biosciences Corp. Formerly Alphanco Venture Corp..
No signal scores available.
This profile gathers the share dealings of Babak Pedram in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. We count 3 filings; the first trade dates from 23 November 2022 and the latest from 1 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 1 September 2026: a share grant, in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations